Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_assertion type Assertion NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_head.
- NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_assertion description "[SNAT3 mRNA showed a 3-5 times stronger expression in gliomas than in metastases or control tissue, and was virtually absent from glioma cultures/glioblastoma immunostained positively with anti-SNAT3 antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_provenance.
- NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_assertion evidence source_evidence_literature NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_provenance.
- NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_assertion SIO_000772 15094455 NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_provenance.
- NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_assertion wasDerivedFrom lhgdn-20090331 NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_provenance.
- NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_assertion wasGeneratedBy ECO_0000203 NP116637.RAptFbJ5ELmLR-lrl_7dFi8TrUWvLVCal_QVdeLl2ZMY4130_provenance.